1-20 of 42
Jeffrey L. Wolf
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes in Patients with Renal Monoclonal Immunoglobulin Deposition Disease

Natasha S Bahri, Alfred Chung, Chiung-Yu Huang, Shagun Arora, Jeffrey L. Wolf, Thomas Martin, Nina Shah, Moming Li, Sandy W. Wong
Journal: Blood
Blood (2022) 140 (Supplement 1): 4285–4286.
https://doi.org/10.1182/blood-2022-167281
Published: 2022
Journal Articles

A Real-World Study on the Feasibility of Minimal Residual Disease Testing By Next-Generation Sequencing in Systemic Light-Chain Amyloidosis

Sireesha Asoori, Alfred Chung, Nina Shah, Shagun Arora, Jeffrey L. Wolf, Thomas Martin, Sandy W. Wong
Journal: Blood
Blood (2022) 140 (Supplement 1): 7233–7234.
https://doi.org/10.1182/blood-2022-168451
Published: 2022
Journal Articles

Significance of the Pee-Value: Relevance of Urine Studies for Patients with Myeloma Undergoing Transplantation

Kelsey H. Natsuhara, Chiung-Yu Huang, Jennifer Knoche, Shagun Arora, Alfred Chung, Thomas Martin, Jeffrey L. Wolf, Sandy W. Wong, Nina Shah, Rahul Banerjee
Journal: Blood
Blood (2022) 140 (Supplement 1): 7910–7912.
https://doi.org/10.1182/blood-2022-155906
Published: 2022
Journal Articles

Safety and Efficacy of BCMA-Targeted CAR-T Therapy in Geriatric Patients with Multiple Myeloma

Kevin R. Reyes, Chiung-Yu Huang, Mimi Lo, Shagun Arora, Alfred Chung, Sandy W. Wong, Jeffrey L. Wolf, Thomas Martin, Nina Shah, Rahul Banerjee
Journal: Blood
Blood (2022) 140 (Supplement 1): 5105–5107.
https://doi.org/10.1182/blood-2022-160362
Published: 2022
Journal Articles

Phase II Study of Pembrolizumab in Multiple Myeloma Patients Relapsing after or Refractory to Anti-BCMA CAR-T Therapies

Alfred Chung, Chiung-Yu Huang, Thomas Martin, Jeffrey L. Wolf, Sandy W. Wong, Nina Shah
Journal: Blood
Blood (2022) 140 (Supplement 1): 12651–12652.
https://doi.org/10.1182/blood-2022-170744
Published: 2022
Journal Articles

Intensity of Cyclophosphamide-Based Bridging Regimens before BCMA-Directed CAR-T Therapy

Aneeqa A Zafar, Chiung-Yu Huang, Mimi Lo, Jen Knoche, Shagun Arora, Alfred Chung, Sandy W. Wong, Jeffrey L. Wolf, Thomas Martin, Nina Shah, Rahul Banerjee
Journal: Blood
Blood (2022) 140 (Supplement 1): 5218–5220.
https://doi.org/10.1182/blood-2022-162122
Published: 2022
Journal Articles

Clinical Outcomes and Salvage Therapies in Patients with Relapsed/Refractory Multiple Myeloma Following Progression on BCMA-Targeted CAR-T Therapy

Kevin R Reyes, Yen-Chun Liu, Chiung-Yu Huang, Rahul Banerjee, Thomas Martin, Nina Shah, Sandy W. Wong, Jeffrey L. Wolf, Shagun Arora, Alfred Chung
Journal: Blood
Blood (2022) 140 (Supplement 1): 617–619.
https://doi.org/10.1182/blood-2022-160401
Published: 2022
Journal Articles

Randomized Study of Digital Life Coaching during Autologous Stem Cell Transplantation

Rahul Banerjee, Ann A. Lazar, Chloe Ryan, Jen Knoche, Kelly Jean Brassil, Lindsey Jackson, Dhiren Patel, Mimi Lo, Shagun Arora, Alfred Chung, Sandy W. Wong, Jeffrey L. Wolf, Thomas Martin, Anand Dhruva, Nina Shah
Journal: Blood
Blood (2021) 138 (Supplement 1): 4023.
https://doi.org/10.1182/blood-2021-147125
Published: 2021
Journal Articles

Impact of Corticosteroids on Efficacy of BCMA Targeted CAR-T Therapy in Multiple Myeloma

Eva Duvalyan, Mimi Lo, Thomas Martin, Jeffrey L. Wolf, Alfred Chung, Shagun Arora, Nina Shah, Chiung-Yu Huang, Sandy W. Wong
Journal: Blood
Blood (2021) 138 (Supplement 1): 1759.
https://doi.org/10.1182/blood-2021-146678
Published: 2021
Journal Articles

Infectious Complications of BCMA-Targeted and CD19-Targeted Chimeric Antigen Receptor T-Cell Immunotherapy

Swetha Kambhampati, MD, Bita Fakhri, MDMPH, Ying Sheng, Chiung-Yu Huang, PhD, Sophia Byslma, BS, Kelsey Natsuhara, MD, Dhruba Biswas, Mimi Lo, PharmD, BCPS, BCOP, Weiyun Z. Ai, Lawrence D Kaplan, MD, Thomas Martin, III, MD, Jeffrey L. Wolf, MD, Nina Shah, MD, Charalambos Andreadis, MD MSCE, Sandy W. Wong, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 4–5.
https://doi.org/10.1182/blood-2020-138940
Published: 2020
Journal Articles

Patterns of Tocilizumab Use Among Myeloma Patients Receiving Bcma-Directed Therapies: Effect on Day 30 Outcomes

Jeffrey Marsal, BS, Rahul Banerjee, MD, Chiung-Yu Huang, PhD, Mimi Lo, PharmD, BCPS, BCOP, Vanessa E Kennedy, MD, Shagun Arora, MD, Jeffrey L. Wolf, MD, Thomas Martin, III, MD, Sandy W. Wong, MD, Nina Shah, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 5–6.
https://doi.org/10.1182/blood-2020-138618
Published: 2020
Journal Articles

Phase II Study of Daratumumab in Combination with Azacitidine and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients Previously Treated with Daratumumab: Darazadex

Swetha Kambhampati, MD, Sandy W. Wong, MD, Thomas Martin, III, MD, Jeffrey L. Wolf, MD, Priya Choudhry, PhD, William Karlon, MD PhD, Arun P. Wiita, MD PhD, Nina Shah, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–28.
https://doi.org/10.1182/blood-2020-138869
Published: 2020
Journal Articles

Macrophage Activation Syndrome-like Manifestations (MAS-L) Following BCMA-Directed CAR T-Cells in Multiple Myeloma

Vanessa E Kennedy, MD, Christopher Wong, Chiung-Yu Huang, PhD, Jeffrey L. Wolf, MD, Thomas Martin, MD, Nina Shah, MD, Sandy W. Wong, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 7–8.
https://doi.org/10.1182/blood-2020-142612
Published: 2020
Journal Articles

Making Clinical Decisions to Change Therapy Using Measurable Residual Disease Improves the Outcome in Multiple Myeloma

Joaquin Martinez Lopez, Rafael Alonso Fernández, Sandy W. Wong, MD, Rafael Rios, MD PhD, Nina Shah, MD, Maria Teresa Cedena Romero, MD PhD, Yanira Ruiz-Heredia, Jose M. Sanchez, MD, Santiago Barrio Garcia, PhD, Thomas Martin, III, MD, Jeffrey L. Wolf, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 42–43.
https://doi.org/10.1182/blood-2020-140352
Published: 2020
Journal Articles

Digital Life Coaching for Myeloma Patients Undergoing Transplantation

Rahul Banerjee, MD, Ann Lazar, PhD MS, Lisa Dunn, RN, Jennifer Knoche, RN, Kelly Jean Brassil, PhD MA, MSN, RN, Dhiren Patel, PharmD, Lindsey Jackson, MPH, CPH, Mimi Lo, PharmD, BCPS, BCOP, Anand Dhruva, MD, Shagun Arora, MD, Sandy W. Wong, MD, Jeffrey L. Wolf, MD, Thomas Martin, III, MD, Nina Shah, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 2–3.
https://doi.org/10.1182/blood-2020-134163
Published: 2020
Journal Articles

Outcomes of Plasma Cell Leukemia Patients in the Era of Next-Generation Novel Agents: A Single-Center Retrospective Cohort Study

Alex Ge, Chiung-Yu Huang, PhD, Thomas Martin, III, MD, Jeffrey L. Wolf, MD, Nina Shah, MD, Sandy W. Wong, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 6–7.
https://doi.org/10.1182/blood-2020-141525
Published: 2020
Journal Articles

Profiling the Cell Surface Landscape of Proteasome Inhibitor-Treated and -Resistant Multiple Myeloma to Guide Immunotherapy Targeting, Diagnosis, and Biology

Ian Ferguson, BA, Yu-Hsiu T. Lin, BA, Sami Tuomivaara, PhD, Jeffrey L. Wolf, MD, Thomas G. Martin, III, MD, Sandy W. Wong, MD, Nina D. Shah, MD, Christoph Driessen, MD, Brian G. Van Ness, PhD, Arun P. Wiita, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1803.
https://doi.org/10.1182/blood-2019-131681
Published: 2019
Journal Articles

Molecular Predictors of Outcome and Drug Response in Multiple Myeloma: An Interim Analysis of the Mmrf CoMMpass Study

Jonathan J Keats, PhD, Gil Speyer, Austin Christofferson, Christophe Legendre, PhD, Jessica Aldrich, Megan Russell, Lori Cuyugan, Jonathan Adkins, Alex Blanski, Meghan Hodges, Dan Rohrer, Sundar Jagannath, MD, Ravi Vij, MD, Gregory Orloff, MD, Todd Zimmerman, MD, Ruben Niesvizky, MD, Darla Liles, MD, Joseph W. Fay, Jeffrey L. Wolf, MD, Robert M Rifkin, Norma C Gutierrez, MD PhD, Mmrf CoMMpass Network, Jennifer Yesil, MS, Mary Derome, MS, Seungchan Kim, PhD, Winnie Liang, PhD, Pamela G. Kidd, MD, Scott Jewell, PhD, John David Carpten, PhD, Daniel Auclair, PhD, Sagar Lonial, MD FACP
Journal: Blood
Blood (2016) 128 (22): 194.
https://doi.org/10.1182/blood.V128.22.194.194
Published: 2016
Journal Articles

Phase Ib Study of Isatuximab and Carfilzomib in Relapse and Refractory Multiple Myeloma

Thomas G. Martin, III, MD, Gabriel N Mannis, Ajai Chari, MD, Pamela Munster, MD, Frank Campana, MD, Ai-Min Hui, MD PhD, Jeffrey L. Wolf, MD
Journal: Blood
Blood (2016) 128 (22): 2111.
https://doi.org/10.1182/blood.V128.22.2111.2111
Published: 2016
Journal Articles

Next-Generation Sequencing Based Minimal Residual Disease Assessment in Peripheral Blood RNA from Multiple Myeloma Patients

Jeffrey L. Wolf, MD, Katherine A. Kong, PhD, Jenai Wilmoth, RN, Joshua Bayes, Amy Marsala, ANP,MPH, Victoria Carlton, PhD, Aaron Logan, MDPhD, Thomas G. Martin, III, MD
Journal: Blood
Blood (2016) 128 (22): 3286.
https://doi.org/10.1182/blood.V128.22.3286.3286
Published: 2016